Aescap
www.aescap.comAescap manages biotech funds investing in innovative high-growth medical companies. It's long-standing out-performance of its bench mark, the Nasdaq Biotech Index is based on a focused portfolio, deep fundamental analyses and a buy and sell discipline. The Aescap funds act under the Article 8 of the EU Sustainable Finance Disclosure Regulation (SFDR) and operate under a AIFM license.
Read more
Aescap manages biotech funds investing in innovative high-growth medical companies. It's long-standing out-performance of its bench mark, the Nasdaq Biotech Index is based on a focused portfolio, deep fundamental analyses and a buy and sell discipline. The Aescap funds act under the Article 8 of the EU Sustainable Finance Disclosure Regulation (SFDR) and operate under a AIFM license.
Read more
Country
City (Headquarters)
Amsterdam
Industry
Employees
11-50
Founded
2016
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Owner
Email ****** @****.comPhone (***) ****-****Founder and Portfolio Manager
Email ****** @****.comPhone (***) ****-****Founder and Managing Partner
Email ****** @****.comPhone (***) ****-****Investment Analyst
Email ****** @****.comPhone (***) ****-****
Technologies
(17)
We'll help you understand if Lusha can solve your business needs.
